Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Malignant Melanoma

  Free Subscription


11.08.2025

1 Am J Dermatopathol
2 Anticancer Res
1 Cancer
1 J Am Acad Dermatol
1 J Immunother
2 J Invest Dermatol
1 Melanoma Res
2 Nat Med
1 Oncogene
1 Ophthalmology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. ZOU Y, Li L, Xia R, Wang F, et al
    Accuracy of Confocal Microscopy for the Diagnosis of Acral Lentiginous Melanoma and Acral Melanocytic Nevi.
    Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003099.
    PubMed         Abstract available


    Anticancer Res

  2. AZUMI J, Takeda T, Shimada Y, Aso H, et al
    Combination of 3-(Trihydroxygermyl)propanoic Acid (THGP) and Lipopolysaccharide Promotes Macrophage Differentiation to M1, and Antitumor Activity.
    Anticancer Res. 2025;45:3425-3440.
    PubMed         Abstract available

  3. YAMADA T, Iwasawa T, Shimizu Y, Kato K, et al
    Resveratrol Enhances Sulfasalazine-induced Ferroptosis by Promoting Iron Ion Accumulation and Lipid Peroxidation in Cancer Cells.
    Anticancer Res. 2025;45:3231-3244.
    PubMed         Abstract available


    Cancer

  4. MILHEM MM, Zakharia Y, Davar D, Buchbinder EI, et al
    Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study.
    Cancer. 2025;131:e70022.
    PubMed         Abstract available


    J Am Acad Dermatol

  5. LIU Q, Yang H, Yu Y, Zhong S, et al
    Cutaneous Melanoma.
    J Am Acad Dermatol. 2025 Jul 31:S0190-9622(25)02548.
    PubMed        


    J Immunother

  6. BHATNAGAR S, Revuri V, Merali C, Wang B, et al
    A Novel Imidazoquinoline With TLR 7/8, STING, and Inflammasome Activity Demonstrates Antitumor Efficacy in Mouse Melanoma and Neu-Driven Mammary Adenocarcinoma.
    J Immunother. 2025 Aug 6. doi: 10.1097/CJI.0000000000000571.
    PubMed         Abstract available


    J Invest Dermatol

  7. CHHABRA G, Su S, Shirley CA, Thornton J, et al
    A melanoma-specific gene network analysis identifies MZB1 (marginal zone B and B1 cell-specific protein) as a potential tumor promoter.
    J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02310.
    PubMed         Abstract available

  8. VAN DEN HURK K, Lommen K, Coussement L, van den Kerkhof D, et al
    Comprehensive analysis of the melanoma DNA methylome identifies Lymphocyte Antigen 75 (LY75) methylation as an independent marker predicting poor clinical outcome.
    J Invest Dermatol. 2025 Jul 30:S0022-202X(25)02311.
    PubMed         Abstract available


    Melanoma Res

  9. CHANG RC, Brunsgaard EK, Reid DC
    Treatment and survival disparities in acral lentiginous melanoma: a National Cancer Database multivariate analysis.
    Melanoma Res. 2025 Aug 5. doi: 10.1097/CMR.0000000000001059.
    PubMed         Abstract available


    Nat Med

  10. BORGERS JSW, Lenkala D, Kohler V, Jackson EK, et al
    Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.
    Nat Med. 2025 Aug 4. doi: 10.1038/s41591-025-03896.
    PubMed        

  11. MIGLINO N, Toussaint NC, Ring A, Bonilla X, et al
    Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanoma.
    Nat Med. 2025 Aug 1. doi: 10.1038/s41591-025-03904.
    PubMed        


    Oncogene

  12. HUANG S, Deng W, Wang P, Yan Y, et al
    Retraction Note: Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-alpha-Pix to Rac1 to activate the MAPK pathway.
    Oncogene. 2025 Aug 5. doi: 10.1038/s41388-025-03524.
    PubMed        


    Ophthalmology

  13. NISSEN K, Ravn Jorgensen AH, Rosthoj S, Thomsen S, et al
    Survival Outcomes of Uveal Melanoma Involving the Anterior Chamber of the Eye. A National Retrospective Cohort Study: Denmark, 1943-2022.
    Ophthalmology. 2025 Jul 30:S0161-6420(25)00461.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.